Filtered By:
Condition: Aortic Stenosis
Procedure: Heart Valve Surgery

This page shows you your search results in order of date.

Order by Relevance | Date

Total 839 results found since Jan 2013.

Novel concept of less invasive concomitant surgical aortic valve replacement and coronary artery bypass grafting avoiding full median sternotomy
AbstractIn the last decades, minimally invasive procedures have been developed in the therapy of aortic valve disorders. Recently, a novel concept of minimally invasive coronary revascularization in multivessel disease via left anterior mini-thoracotomy demonstrated promising results. Full median sternotomy, as a very invasive procedure, is the standard approach in concomitant surgical aortic valve replacement (sAVR) and coronary bypass grafting (CABG). The aim of our study was to show that the combination of minimal invasive aortic valve replacement via upper mini-sternotomy and coronary artery bypass grafting via left an...
Source: Heart and Vessels - September 12, 2023 Category: Cardiology Source Type: research

Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial
EuroIntervention. 2023 Sep 1:EIJ-D-23-00232. doi: 10.4244/EIJ-D-23-00232. Online ahead of print.ABSTRACTTranscatheter aortic valve implantation (TAVI) has become the preferred treatment option for patients with severe aortic stenosis at increased risk for surgical aortic valve replacement (SAVR) and for older patients irrespective of risk. However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy remains controversial, as data on long-term outcomes remain limited. The DEDICATE-DZHK6 Trial is an investigator-initiated, industry-independent, prospe...
Source: EuroIntervention - September 1, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Moritz Seiffert Reinhard Vonthein Helmut Baumgartner Michael A Borger Yeong-Hoon Choi Volkmar Falk Norbert Frey Andreas Hagendorff Christian Hagl Christian Hamm Inke R K önig Ulf Landmesser Steffen Massberg Hermann Reichenspurner Holger Thiele Raphael Tw Source Type: research

Early Aortic Valve Replacement in Symptomatic Normal-Flow, Low-Gradient Severe Aortic Stenosis: A Propensity Score-Matched Retrospective Cohort Study
CONCLUSIONS: An early AVR strategy may be beneficial in reducing the risk of a composite outcome of death or hospitalization for HF in symptomatic patients with NFLG severe AS. Future randomized studies are required to validate and confirm our findings.PMID:37653715 | DOI:10.4070/kcj.2023.0022
Source: Korean Circulation Journal - September 1, 2023 Category: Cardiology Authors: Kyu Kim Iksung Cho Kyu-Yong Ko Seung-Hyun Lee Sak Lee Geu-Ru Hong Jong-Won Ha Chi Young Shim Source Type: research

Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial
EuroIntervention. 2023 Sep 1:EIJ-D-23-00232. doi: 10.4244/EIJ-D-23-00232. Online ahead of print.ABSTRACTTranscatheter aortic valve implantation (TAVI) has become the preferred treatment option for patients with severe aortic stenosis at increased risk for surgical aortic valve replacement (SAVR) and for older patients irrespective of risk. However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy remains controversial, as data on long-term outcomes remain limited. The DEDICATE-DZHK6 Trial is an investigator-initiated, industry-independent, prospe...
Source: EuroIntervention - September 1, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Moritz Seiffert Reinhard Vonthein Helmut Baumgartner Michael A Borger Yeong-Hoon Choi Volkmar Falk Norbert Frey Andreas Hagendorff Christian Hagl Christian Hamm Inke R K önig Ulf Landmesser Steffen Massberg Hermann Reichenspurner Holger Thiele Raphael Tw Source Type: research

Early Aortic Valve Replacement in Symptomatic Normal-Flow, Low-Gradient Severe Aortic Stenosis: A Propensity Score-Matched Retrospective Cohort Study
CONCLUSIONS: An early AVR strategy may be beneficial in reducing the risk of a composite outcome of death or hospitalization for HF in symptomatic patients with NFLG severe AS. Future randomized studies are required to validate and confirm our findings.PMID:37653715 | DOI:10.4070/kcj.2023.0022
Source: Korean Circulation Journal - September 1, 2023 Category: Cardiology Authors: Kyu Kim Iksung Cho Kyu-Yong Ko Seung-Hyun Lee Sak Lee Geu-Ru Hong Jong-Won Ha Chi Young Shim Source Type: research

Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial
EuroIntervention. 2023 Sep 1:EIJ-D-23-00232. doi: 10.4244/EIJ-D-23-00232. Online ahead of print.ABSTRACTTranscatheter aortic valve implantation (TAVI) has become the preferred treatment option for patients with severe aortic stenosis at increased risk for surgical aortic valve replacement (SAVR) and for older patients irrespective of risk. However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy remains controversial, as data on long-term outcomes remain limited. The DEDICATE-DZHK6 Trial is an investigator-initiated, industry-independent, prospe...
Source: EuroIntervention - September 1, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Moritz Seiffert Reinhard Vonthein Helmut Baumgartner Michael A Borger Yeong-Hoon Choi Volkmar Falk Norbert Frey Andreas Hagendorff Christian Hagl Christian Hamm Inke R K önig Ulf Landmesser Steffen Massberg Hermann Reichenspurner Holger Thiele Raphael Tw Source Type: research

Early Aortic Valve Replacement in Symptomatic Normal-Flow, Low-Gradient Severe Aortic Stenosis: A Propensity Score-Matched Retrospective Cohort Study
CONCLUSIONS: An early AVR strategy may be beneficial in reducing the risk of a composite outcome of death or hospitalization for HF in symptomatic patients with NFLG severe AS. Future randomized studies are required to validate and confirm our findings.PMID:37653715 | DOI:10.4070/kcj.2023.0022
Source: Korean Circulation Journal - September 1, 2023 Category: Cardiology Authors: Kyu Kim Iksung Cho Kyu-Yong Ko Seung-Hyun Lee Sak Lee Geu-Ru Hong Jong-Won Ha Chi Young Shim Source Type: research

Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial
EuroIntervention. 2023 Sep 1:EIJ-D-23-00232. doi: 10.4244/EIJ-D-23-00232. Online ahead of print.ABSTRACTTranscatheter aortic valve implantation (TAVI) has become the preferred treatment option for patients with severe aortic stenosis at increased risk for surgical aortic valve replacement (SAVR) and for older patients irrespective of risk. However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy remains controversial, as data on long-term outcomes remain limited. The DEDICATE-DZHK6 Trial is an investigator-initiated, industry-independent, prospe...
Source: EuroIntervention - September 1, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Moritz Seiffert Reinhard Vonthein Helmut Baumgartner Michael A Borger Yeong-Hoon Choi Volkmar Falk Norbert Frey Andreas Hagendorff Christian Hagl Christian Hamm Inke R K önig Ulf Landmesser Steffen Massberg Hermann Reichenspurner Holger Thiele Raphael Tw Source Type: research

Early Aortic Valve Replacement in Symptomatic Normal-Flow, Low-Gradient Severe Aortic Stenosis: A Propensity Score-Matched Retrospective Cohort Study
CONCLUSIONS: An early AVR strategy may be beneficial in reducing the risk of a composite outcome of death or hospitalization for HF in symptomatic patients with NFLG severe AS. Future randomized studies are required to validate and confirm our findings.PMID:37653715 | DOI:10.4070/kcj.2023.0022
Source: Korean Circulation Journal - September 1, 2023 Category: Cardiology Authors: Kyu Kim Iksung Cho Kyu-Yong Ko Seung-Hyun Lee Sak Lee Geu-Ru Hong Jong-Won Ha Chi Young Shim Source Type: research